We are live on ! Find out more
SCA

Stonebridge Capital Advisors Portfolio holdings

AUM $1.43B
1-Year Est. Return 21.98%
This Fund
S&P 500
This Quarter Est. Return
+4.54%
1 Year Est. Return
+21.98%
3 Year Est. Return
+64.22%
5 Year Est. Return
+80.67%
10 Year Est. Return
+293.7%
AUM
$243M
AUM Growth
+$16.5M
Cap. Flow
+$9.08M
Cap. Flow %
3.73%
Top 10 Hldgs %
26.15%
Holding
160
New
10
Increased
88
Reduced
33
Closed
7

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$1.15M
2
UN
Unilever NV New York Registry Shares
UN
+$753K
3
BHP icon
BHP
BHP
+$513K
4
KMI icon
Kinder Morgan
KMI
+$490K
5
CVX icon
Chevron
CVX
+$483K

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$1.37M
2
ZTS icon
Zoetis
ZTS
+$710K
3
KMP
KINDER MORGAN ENER PNTRS L.P.
KMP
+$492K
4
FLR icon
Fluor
FLR
+$387K
5
RYN icon
Rayonier
RYN
+$355K

Sector Composition

Rank Sector Weight
1 Financials 15.23%
2 Consumer Discretionary 12.96%
3 Industrials 11.99%
4 Technology 11.38%
5 Consumer Staples 10.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HIV
151
DELISTED
CALYPTE BIOMEDICAL CORP NEW
HIV
$0 ﹤0.01%
11,800
– –
AGN
152
DELISTED
Allergan Inc
AGN
– –
-7,675
Closed -$1.37M
3 4 5 6
7

Similar funds

SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.43B AUM 22.07% 1-Year Est. Return
TS
Triglav Skladi Ljubljana, Slovenia $1.43B AUM 39.24% 1-Year Est. Return
APCM
Alaska Permanent Capital Management Anchorage, Alaska $1.43B AUM 13.12% 1-Year Est. Return
CCM
Callodine Capital Management Boston, Massachusetts $1.43B AUM 8.74% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.43B AUM 9.81% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return
SC
Styrax Capital New York $1.43B AUM 50.63% 1-Year Est. Return

Stonebridge Capital Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, Stonebridge Capital Advisors held 160 positions worth $243M, up 7.3% from $227M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Stonebridge Capital Advisors deployed $9.08M of net new capital in Q4 2014, opening 10 new positions and adding to 88 existing holdings. Its largest new stake was Unilever NV New York Registry Shares: 19,251 shares worth $752K.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Zoetis, an estimated $710K trimmed.

  • Stonebridge Capital Advisors's largest Q4 2014 buy was Unilever NV New York Registry Shares: 19,251 shares worth $752K.
  • Stonebridge Capital Advisors added most to Novartis in Q4 2014, an estimated $1.15M increase.
  • Stonebridge Capital Advisors's biggest Q4 2014 reduction was Zoetis, cutting an estimated $710K.
  • Stonebridge Capital Advisors fully exited Allergan Inc in Q4 2014, selling an estimated $1.37M.
  • Stonebridge Capital Advisors's ten largest holdings make up 26% of its $243M portfolio in Q4 2014.
  • Stonebridge Capital Advisors opened 10 new positions and closed 7 in Q4 2014.
  • Stonebridge Capital Advisors's portfolio value rose 7.3% quarter-over-quarter to $243M.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.